retatrutide peptide side effects (LY3437943) — Dosing, Effects, FDA Status & Research | PeptIQ Retatrutide Side Effects | Everest

However, the mechanistic rationale for combining these agents is sound and warrants further investigation

Regardless of mechanism, clinical observations support a nausea-reducing effect in a subset of users

for semaglutide, a 2-month washout period is recommended before conception) [1] Certain eating disorder subtypes, particularly those with purging behaviours or severe restriction Any decision to prescribe GLP-1 agonists should involve multidisciplinary input , ideally including endocrinology or weight management specialists, mental health professionals with eating disorder expertise, and the patient's GP

1,16 References Gul, M., Liu, Z., Haq, I., et al

2022;12(s1):S13747